These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 30980201)

  • 1. [Ketamine in the therapy of chronic pain and depression].
    Jaksch W; Likar R; Aigner M
    Wien Med Wochenschr; 2019 Nov; 169(15-16):367-376. PubMed ID: 30980201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analgesic effect of subanesthetic intravenous ketamine in refractory neuropathic pain: a case report.
    Elsewaisy O; Slon B; Monagle J
    Pain Med; 2010 Jun; 11(6):946-50. PubMed ID: 20624244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analgesic effect of oral ketamine in chronic neuropathic pain of spinal origin: a case report.
    Fisher K; Hagen NA
    J Pain Symptom Manage; 1999 Jul; 18(1):61-6. PubMed ID: 10439575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketamine for chronic pain: risks and benefits.
    Niesters M; Martini C; Dahan A
    Br J Clin Pharmacol; 2014 Feb; 77(2):357-67. PubMed ID: 23432384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How effective is ketamine in the management of chronic neuropathic pain?
    Shteamer JW; Callaway MA; Patel P; Singh V
    Pain Manag; 2019 Nov; 9(6):517-519. PubMed ID: 31613180
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral ketamine for the treatment of pain and treatment-resistant depression†.
    Schoevers RA; Chaves TV; Balukova SM; aan het Rot M; Kortekaas R
    Br J Psychiatry; 2016 Feb; 208(2):108-13. PubMed ID: 26834167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of a multiday (10-14 days) subanesthetic dose IV ketamine infusion in the treatment of refractory chronic pain.
    Chebini A; Marzoughi S; Randhawa J; Guh D; Wiseman S; Fedoroff I; Ong M
    Pain Manag; 2022 Apr; 12(3):337-346. PubMed ID: 34528840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging concepts on the use of ketamine for chronic pain.
    Yang Y; Maher DP; Cohen SP
    Expert Rev Clin Pharmacol; 2020 Feb; 13(2):135-146. PubMed ID: 31990596
    [No Abstract]   [Full Text] [Related]  

  • 9. Ketamine for cancer pain: what is the evidence?
    Jonkman K; van de Donk T; Dahan A
    Curr Opin Support Palliat Care; 2017 Jun; 11(2):88-92. PubMed ID: 28306568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analgesic effects of topical ketamine.
    Kopsky DJ; Keppel Hesselink JM; Bhaskar A; Hariton G; Romanenko V; Casale R
    Minerva Anestesiol; 2015 Apr; 81(4):440-9. PubMed ID: 24847738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term ketamine subcutaneous continuous infusion in neuropathic cancer pain.
    Mercadante S; Lodi F; Sapio M; Calligara M; Serretta R
    J Pain Symptom Manage; 1995 Oct; 10(7):564-8. PubMed ID: 8537699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case report: efficacy and tolerability of ketamine in opioid-refractory cancer pain.
    Amin P; Roeland E; Atayee R
    J Pain Palliat Care Pharmacother; 2014 Sep; 28(3):233-42. PubMed ID: 25102039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concentration-effect relationship of intravenous alfentanil and ketamine on peripheral neurosensory thresholds, allodynia and hyperalgesia of neuropathic pain.
    Leung A; Wallace MS; Ridgeway B; Yaksh T
    Pain; 2001 Mar; 91(1-2):177-87. PubMed ID: 11240090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic administration of ketamine for analgesia.
    Ben-Ari A; Lewis MC; Davidson E
    J Pain Palliat Care Pharmacother; 2007; 21(1):7-14. PubMed ID: 17430824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and pharmacodynamic considerations for NMDA receptor antagonists in the treatment of chronic neuropathic pain.
    Niesters M; Dahan A
    Expert Opin Drug Metab Toxicol; 2012 Nov; 8(11):1409-17. PubMed ID: 22871026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of ketamine in pain management.
    Visser E; Schug SA
    Biomed Pharmacother; 2006 Aug; 60(7):341-8. PubMed ID: 16854557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of antinociceptive effect of ketamine in acute and neuropathic pain models in rats.
    Doncheva ND; Vasileva L; Saracheva K; Dimitrova D; Getova D
    Adv Clin Exp Med; 2019 May; 28(5):573-579. PubMed ID: 30561175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ketamine for pain: an update of uses in palliative care.
    Prommer EE
    J Palliat Med; 2012 Apr; 15(4):474-83. PubMed ID: 22500483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ketamine for chronic noncancer pain: concerns regarding toxicity.
    Bell RF
    Curr Opin Support Palliat Care; 2012 Jun; 6(2):183-7. PubMed ID: 22436323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropathic Pain in Pediatric Oncology: A Clinical Decision Algorithm.
    Anghelescu DL; Tesney JM
    Paediatr Drugs; 2019 Apr; 21(2):59-70. PubMed ID: 30761460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.